Pediatric Health Medicine and Therapeutics,
Journal Year:
2024,
Volume and Issue:
Volume 15, P. 351 - 364
Published: Nov. 1, 2024
To
establish
the
noninferiority
of
rapid
and
sensitive
multiplex
polymerase
chain
reaction
(M-PCR)
method
versus
standard
urine
culture
(SUC)
in
pediatric
urinary
tract
infection
(UTI)
diagnostic
testing.
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 31, 2024
Abstract
Background
Current
diagnoses
of
urinary
tract
infection
(UTI)
by
standard
urine
culture
(SUC)
has
significant
limitations
in
sensitivity,
especially
for
fastidious
organisms,
and
the
ability
to
identify
organisms
polymicrobial
infections.
The
rate
both
SUC
“negative”
or
“mixed
flora/contamination”
results
UTI
cases
high
prevalence
asymptomatic
bacteriuria
indicate
need
an
accurate
diagnostic
test
help
true
cases.
This
study
aimed
determine
if
infection-associated
biomarkers
can
differentiate
definitive
from
non-UTI
controls.
Methods
Midstream
clean-catch
voided
samples
were
collected
volunteers
symptomatic
subjects
≥
60
years
old
diagnosed
with
a
urology
specialty
setting.
Microbial
identification
density
assessed
using
multiplex
PCR/pooled
antibiotic
susceptibility
(M-PCR/P-AST)
SUC.
Three
[neutrophil
gelatinase-associated
lipocalin
(NGAL),
Interleukins
8
1β
(IL-8,
IL-1β)]
also
measured
via
enzyme-linked
immunosorbent
assay
(ELISA).
Definitive
defined
as
diagnosis
positive
microorganism
detection
M-PCR,
while
volunteers.
Results
We
observed
strong
correlation
(R
2
>
0.90;
p
<
0.0001)
between
microbial
NGAL,
IL-8,
IL-1β
subjects.
Biomarker
consensus
criteria
two
more
had
sensitivity
84.0%,
specificity
91.2%,
predictive
value
93.7%,
negative
78.8%,
accuracy
86.9%,
likelihood
ratio
9.58,
0.17
differentiating
cases,
regardless
non-zero
density.
showed
elevation
microbe
compared
without
identification.
exhibited
distinguishing
Conclusion
demonstrated
that
IL-1β,
and/or
M-PCR
was
associated
A
criterion
meeting
positivity
thresholds
good
balance
(84.0%),
(91.2%),
(86.9%).
Therefore,
this
biomarker
is
excellent
supportive
tool
resolving
presence
active
UTI,
particularly
disagree.
Research and Reports in Urology,
Journal Year:
2024,
Volume and Issue:
Volume 16, P. 19 - 29
Published: Jan. 1, 2024
Background:
Many
emerging
uropathogens
are
currently
identified
by
multiplex
polymerase
chain
reaction
(M-PCR)
in
suspected
UTI
cases.
Standard
urine
culture
(SUC)
has
significantly
lower
detection
rates,
raising
questions
about
whether
these
organisms
associated
with
UTIs
and
truly
cause
inflammation.
Objective:
To
determine
if
microbes
detected
M-PCR
were
likely
causative
of
measuring
inflammatory
biomarkers
the
symptomatic
patients.
Design,
Setting,
Participants:
Midstream
voided
was
collected
from
subjects
≥
60
years
presenting
to
urology
clinics
symptoms
(n
=
1132)
between
01/2023
05/2023.
Microbe
inflammation-associated
biomarker
(neutrophil
gelatinase-associated
lipocalin,
interleukin
8,
1β)
enzyme-linked
immunosorbent
assay.
Biomarker
positivity
measured
against
individual
groups
organisms,
E.
coli
non-
cases,
uropathogens,
monomicrobial
polymicrobial
Outcome
Measurements
Statistical
Analysis:
Distributions
compared
using
2-sample
Wilcoxon
Rank
Sum
test
2-tailed
p-values
<
0.05
considered
statistically
significant.
Results
Limitations:
positive
823
(72.7%)
specimens
28
30
(93%)
microorganisms/groups
detected.
Twenty-six
twenty-eight
had
2
>
66%
Both
cases
significant
(p
0.05).
Limitations
that
a
few
low
prevalence
making
inferences
their
significance
difficult.
Conclusion:
The
majority
microorganisms
active
inflammation
positivity,
indicating
they
This
includes
frequently
not
standard
culture.
Plain
Language
Summary:
assay
is
novel
diagnostic
for
UTI.
study
found
most
included
were:detected
patients
at
least
age
presumptive
diagnosisassociated
infection
Thus,
assay:is
clinically
relevanthas
likelihood
false-positivity
Keywords:
testing,
IL-8,
IL-1β,
M-PCR,
NGAL,
Journal of Clinical Microbiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 6, 2025
ABSTRACT
Urinary
tract
infections
(UTIs)
impose
a
substantial
burden
on
patient
quality
of
life
and
urine
testing
accounts
for
the
majority
workload
in
many
clinical
microbiology
laboratories.
Traditional
UTI
diagnosis
relies
symptoms,
urinalysis,
culture
which
are
interpreted
based
historical
guidelines.
This
approach,
while
foundational,
presents
limitations,
particularly
complex
cases.
Low-level
bacteriuria
presence
fastidious
organisms
often
overlooked
or
entirely
missed
standard
culture,
stressing
need
novel
diagnostic
methods
technologies.
mini-review
summarizes
existing
state
diagnostics
2024
covers
current
upcoming
technologies
including
rapid
molecular-based
pathogen
identification,
next-generation
sequencing,
advanced
antimicrobial
susceptibility
testing.
However,
these
represent
unique
challenges,
as
they
implemented,
will
require
field
to
adapt
new
concepts
avoid
misdiagnosis
overtreatment.
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 143 - 143
Published: Feb. 1, 2025
Background/Objectives:
Urinary
tract
infections
(UTIs)
pose
an
increasing
risk
of
antimicrobial
resistance,
and
novel
diagnostic
tests
have
been
developed
to
address
the
limitations
standard
urine
culture
in
these
cases.
It
is
important
that
be
validated
for
agreement
error
rates
against
antibiotic
susceptibility
testing
(AST)
methods.
Methods:
Polymicrobial
(≥two
non-fastidious
microorganisms)
consecutive
clinical
specimens
submitted
UTI
were
included
this
analysis.
Specimens
tested
with
Pooled
Antibiotic
Susceptibility
Testing
(P-AST)
broth
microdilution/disk
diffusion
(BMD/DD)
parallel.
Performance
characteristics,
such
as
essential
(EA%),
very
major
errors
(VMEs),
(MEs),
assessed
using
Clinical
Laboratory
Standards
Institute
(CLSI)
standards.
P-AST-resistant
BMD/DD
consensus-sensitive
results
heteroresistance.
Real-world
sample
data
used
assess
associations
between
organism
counts
average
“sensitive”
count
per
sample.
Results:
The
P-AST
isolate
AST
was
≥90%,
VMEs
<2.0%,
MEs
<3.0%,
meeting
CLSI
guidelines
verification
validation
studies.
When
heteroresistance
accounted
for,
overall
both
<1.5%.
presence
additional
organisms
dropped
number
antibiotics
from
9.8
one
2.5
five
or
more
organisms.
fastidious
did
not
any
meaningful
impact.
Conclusions:
P-AST,
a
component
Guidance®
assay
(Pathnostics,
Irvine,
CA,
USA),
performed
within
standards
polymicrobial
specimens.
European Urology Open Science,
Journal Year:
2023,
Volume and Issue:
58, P. 73 - 81
Published: Nov. 8, 2023
Multiplex
polymerase
chain
reaction
(M-PCR)
has
increased
sensitivity
for
microbial
detection
compared
with
standard
urine
culture
(SUC)
in
cases
diagnosed
as
urinary
tract
infections
(UTIs),
leading
to
questions
whether
detected
microbes
are
likely
causative
of
UTIs
or
incidental
findings.
To
compare
infection-associated
biomarker
levels
against
M-PCR
and
SUC
results
symptomatic
a
presumptive
diagnosis
UTI
by
urologist.
Participants
were
≥60
yr
old
presented
urology
clinics
between
January
April
2023
symptoms
(n
=
583).
Urine
was
SUC.
Three
biomarkers
(neutrophil
gelatinase-associated
lipocalin,
interleukin-8,
interleukin-1β)
measured
enzyme-linked
immunosorbent
assay.
Symptomatic
elevated
biomarkers,
uropathogens,
specialist
clinical
considered
definitive
cases.
Distributions
using
two-sample
Wilcoxon
rank
sum
test,
two-tailed
p
values
<0.05
statistically
significant.
In
M-PCR–positive/SUC-negative
80),
all
median
significantly
higher
(p
<
0.0001)
than
M-PCR–negative/SUC-negative
107).
Two
more
positive
76%
specimens.
Limitation
an
inability
examine
associations
each
individual
organism
inflammation.
A
significant
number
had
infection-related
especially
when
infection
caused
organisms
other
Escherichia
coli.
This
is
strong
indication
that
M-PCR,
which
would
be
missed
SUC,
associated
UTIs.
We
patients
(UTIs)
the
microorganisms
multiplex
(M-PCR).
found
most
markers
inflammation,
indicating
these
Infection and Drug Resistance,
Journal Year:
2023,
Volume and Issue:
Volume 16, P. 7775 - 7795
Published: Dec. 1, 2023
Introduction:
This
study
compared
microbial
compositions
of
midstream
and
catheter
urine
specimens
from
patients
with
suspected
complicated
urinary
tract
infections
to
determine
if
emerging
fastidious
uropathogens
are
infecting
the
bladder
or
contaminants.
Methods:
Urine
was
collected
by
in-and-out
(n
=
1000)
voiding
2000
adult
(≥
60
years
age)
at
17
DispatchHealth
sites
across
11
states.
The
two
groups
were
matched
age
(mean
81
years),
sex
(62.1%
female,
37.9%
male),
ICD-10-CM
codes.
Microbial
detection
performed
multiplex
polymerase
chain
reaction
(M-PCR)
a
threshold
for
"positive
detection"
≥
10,000
cells/mL
bacteria
any
yeast.
Results
divided
sex.
Results:
In
females,
28
30
microorganisms/groups
found
both
collection
methods,
while
in
males
26
both.
There
significant
overlaps
densities
classical
including
Escherichia
coli,
Enterococcus
faecalis
,
Klebsiella
pneumoniae
as
well
Actinotignum
schaalii
Aerococcus
urinae
.
rates
slightly
higher
voided
catheter-collected
(p
0.0005)
samples,
showed
opposite
trend
<
0.0001).
More
polymicrobial
detected
samples
(64.4%
vs
45.7%,
p
0.0001)
females
but
(35.6%
47.0%,
0.002).
Discussion:
In-and-out
shared
similarities
detections
M-PCR,
some
differences
small
subset
organisms
between
sexes.
Conclusion:
Non-invasive
identification
cases
presumed
UTI
does
not
result
significantly
more
contamination
specimens.
Additionally,
long
regarded
contaminants
should
be
reconsidered
potential
uropathogens.
Keywords:
infection,
standard
culture,
diagnostic
testing,
reaction,
catheter,
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(12), P. 6616 - 6616
Published: June 16, 2024
While
urinary
polymerase
chain
reaction
(PCR)
testing
is
effective
in
organism
identification
patients
with
complex
tract
infections
(cUTI),
limited
data
exists
on
the
clinical
usefulness
of
this
test.
We
serially
surveyed
physicians
treating
symptomatic
cUTI
both
at
presentation
and
after
PCR,
urine
culture
(UC)
results
were
available
to
ascertain
how
test
modified
therapy.
A
total
96
unique
surveys
completed
by
21
providers
included
analysis.
The
mean
age
for
female
male
was
69.4
±
15.5
71.6
12.7
years,
respectively.
positivity
line–item
concordance
UC
PCR
consistent
prior
reports.
or
confirmed
treatment
59/96
(61.5%)
25/96
(26.0%)
cases,
respectively,
12/29
(41.4%)
47/67
(70.1%)
having
negative
positive
results,
resulting
change
(difference
28.7%,
p
<
0.01).
Of
these,
55/59
(57.3%)
alterations
antibiotic
regimen.
use
modify
similar
across
not
statistically
different
when
stratified
patient
age,
gender,
empiric
In
31/59
(52.5%)
where
would
not;
conversely,
have
3/37
(8.1%)
cases
did
44.4%,
find
that
are
used
clinicians
managing
cUTI,
provides
an
opportunity
improve
stewardship
difficult-to-treat
subset
patients.
Clinical Microbiology Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 6, 2024
SUMMARY
Urinary
tract
infection
(UTI)
is
among
the
most
common
infections
in
clinical
practice.
In
some
cases,
if
left
untreated,
it
can
lead
to
pyelonephritis
and
urosepsis.
other
UTI
resolves
without
treatment.
Clinical
diagnosis
typically
based
on
patient
symptoms
and/or
urinalysis,
including
urine
dipsticks.
The
standard
culture
method
sometimes
employed
identify
suspected
urinary
pathogen
(uropathogen)
guide
antimicrobial
choice,
but
results
are
rarely
available
before
24
h.
also
misses
fastidious,
anaerobic,
slow-growing
uropathogens
reports
polymicrobial
infections.
unexplained
combination
of
negative
cultures
with
persistent
distressing
both
patients
clinicians.
Given
broad
appreciation
advantages
provided
by
rapid
testing
(e.g.,
for
COVID-19
or
influenza
A),
a
rapid,
accurate
diagnostic
test
needed
deliver
timely
treatment
seeking
care
that
optimizes
antibiotic
stewardship.
Herein,
we
discuss
progress
being
made
toward
an
accessible,
(i.e.,
within
hours),
assay
clinically
useful
treating
clinician
timeframe
growth
rate
pathogen(s)).
New
emerging
often
overlooked
current
techniques
reviewed.
Antibiotics,
Journal Year:
2024,
Volume and Issue:
13(12), P. 1214 - 1214
Published: Dec. 14, 2024
Background/Objectives:
While
new
methods
for
measuring
antimicrobial
susceptibility
have
been
associated
with
improved
patient
outcomes,
they
should
also
be
validated
using
standard
protocols
error
rates
and
other
test
metrics.
The
objective
of
this
study
was
to
validate
a
novel
assay
complicated
recurrent
urinary
tract
infections
(UTIs):
pooled
antibiotic
testing
(P-AST).
This
compared
broth
microdilution
(BMD)
disk
diffusion
(DD),
following
Clinical
Laboratory
Standards
Institute
(CLSI)
guidelines
assessment
agreement.
Methods:
analyzed
consecutive
fresh
clinical
urine
specimens
submitted
UTI
diagnostic
testing.
Upon
receipt,
the
samples
were
subjected
in
parallel
culture
multiplex
polymerase
chain
reaction
(M-PCR)
microbial
identification
quantification.
Specimens
same
monomicrobial
non-fastidious
bacteria
detected
by
both
M-PCR
(SUC)
underwent
(AST)
P-AST
Analysis
undertaken
assess
presence
heteroresistance
P-AST-resistant
BMD/DD
consensus-susceptible
results.
Results:
performance
measures
without
correction
showed
essential
agreement
(EA%)
≥90%,
very
major
errors
(VMEs)
<1.5%,
(MEs)
<3.0%
P-AST,
all
meeting
threshold
established
CLSI
AST.
categorical
(CA%)
met
acceptable
criteria
(>88%),
as
majority
minor
(mEs)
decreased
<1.0%
when
accounted
for.
Conclusions:
methodology
is
within
parameters
criteria.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(23), P. 7453 - 7453
Published: Dec. 7, 2024
We
aimed
to
compare
the
prescribing
behavior
and
clinical
experience
of
urology
providers
when
using
combined
multiplex
polymerase
chain
reaction
(M-PCR)/Pooled
Antibiotic
Susceptibility
Testing
(P-AST)
diagnostic
test
versus
standard
urine
culture
(SUC)
in
same
set
patients
previously
reported
have
improved
outcomes
with
M-PCR/P-AST.